Hyun Chang Selected Research

Lung Neoplasms (Lung Cancer)

12/2019	Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer.
1/2019	Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.
1/2017	EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells.
1/2016	EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy.
3/2014	Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyun Chang Research Topics

Disease

18	Neoplasms (Cancer) 07/2023 - 01/2006
10	Stomach Neoplasms (Stomach Cancer) 03/2017 - 01/2006
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 10/2009
5	Squamous Cell Carcinoma of Head and Neck 07/2021 - 01/2019
5	Lung Neoplasms (Lung Cancer) 12/2019 - 03/2014
4	Neoplasm Metastasis (Metastasis) 09/2019 - 01/2006
4	Infections 12/2015 - 09/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 09/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2019 - 10/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 07/2015
2	Disease Progression 01/2017 - 03/2013
2	Adenocarcinoma of Lung 04/2016 - 03/2014
2	Ulcer 01/2014 - 04/2012
2	Breast Neoplasms (Breast Cancer) 01/2011 - 08/2010
1	Hepatocellular Carcinoma (Hepatoma) 07/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Lymphatic Metastasis 09/2019
1	Adenocarcinoma 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2017
1	Carcinogenesis 03/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Airway Obstruction (Choking) 02/2015
1	Inflammation (Inflammations) 12/2014
1	Carcinoma (Carcinomatosis) 07/2014
1	Polyps 05/2014

Drug/Important Bio-Agent (IBA)

6	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 01/2010
5	Immune Checkpoint InhibitorsIBA 07/2021 - 09/2019
5	Biomarkers (Surrogate Marker)IBA 07/2021 - 12/2010
4	Tyrosine Kinase InhibitorsIBA 12/2019 - 03/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 09/2013
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2014
3	PlatinumIBA 07/2021 - 07/2014
3	Messenger RNA (mRNA)IBA 07/2020 - 09/2013
2	AntibodiesIBA 01/2023 - 03/2014
2	Etoposide (VP 16)FDA LinkGeneric 10/2017 - 08/2012
2	MicroRNAs (MicroRNA)IBA 03/2017 - 03/2015
2	CrizotinibIBA 01/2017 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 04/2014
2	Gefitinib (Iressa)FDA Link 01/2017 - 03/2013
2	Cisplatin (Platino)FDA LinkGeneric 04/2014 - 08/2012
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014 - 04/2012
2	Taxoids (Taxanes)IBA 01/2011 - 12/2010
2	taxaneIBA 01/2011 - 12/2010
2	Histone Deacetylase InhibitorsIBA 01/2011 - 12/2010
2	Vorinostat FDA Link 01/2011 - 12/2010
2	Docetaxel (Taxotere)FDA Link 12/2010 - 08/2010
1	beta Adrenergic ReceptorsIBA 07/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2023
1	Combined VaccinesIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	InterferonsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	VaccinesIBA 01/2023
1	Hormones (Hormone)IBA 01/2021
1	cerivastatin (Kazak)FDA Link 12/2019
1	Mevalonic Acid (Mevalonate)IBA 12/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2019
1	isoliquiritigenin (GU 17)IBA 09/2019
1	Blood Glucose (Blood Sugar)IBA 05/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2019
1	Trefoil Factor-2IBA 01/2018
1	EnzymesIBA 10/2017
1	CamptothecinIBA 10/2017
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	vandetanib (ZD6474)IBA 01/2017
1	lenvatinibIBA 01/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Formaldehyde (Formol)FDA Link 04/2016
1	ParaffinIBA 04/2016
1	CTLA-4 AntigenIBA 01/2016
1	B7-H1 AntigenIBA 01/2016
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2016
1	CarcinogensIBA 12/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015
1	Cytotoxins (Cytolysins)IBA 12/2015
1	Gemcitabine FDA Link 07/2015
1	p21-Activated KinasesIBA 07/2015
1	VimentinIBA 05/2015
1	Cadherins (E-Cadherin)IBA 05/2015
1	AntioxidantsIBA 12/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2014

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 07/2021 - 10/2006
6	Therapeutics 01/2023 - 01/2016
3	Radiotherapy 12/2020 - 03/2014
2	Adjuvant Chemotherapy 09/2019 - 03/2010
2	Chemoradiotherapy 04/2014 - 08/2012
1	Transplantation 01/2023
1	Castration 01/2021
1	Immunotherapy 07/2020
1	Cystectomy 09/2019
1	Neoadjuvant Therapy 09/2019
1	Molecular Targeted Therapy 01/2019
1	Precision Medicine 01/2019
1	Tracheostomy 02/2015
1	Combination Drug Therapy (Combination Chemotherapy) 07/2014
1	Salvage Therapy 07/2014